SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000019617-24-000547
Filing Date
2024-10-10
Accepted
2024-10-10 12:36:28
Documents
1
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 FILING INTRA-CELLULAR THERAPIES, INC. INTRACELLULAR_THERAPIES_IN.htm SC 13G 88198
  Complete submission text file 0000019617-24-000547.txt   90172
Mailing Address 383 MADISON AVENUE NEW YORK NY 10017
Business Address 383 MADISON AVENUE NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

IRS No.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6021 National Commercial Banks
(CF Office: 02 Finance)

Mailing Address 135 ROUTE 202/206 BEDMINSTER NJ 07921
Business Address 135 ROUTE 202/206 BEDMINSTER NJ 07921 (646) 440-9333
Intra-Cellular Therapies, Inc. (Subject) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87380
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)